LRRK2 — World Parkinson Congress Blog

Posts tagged LRRK2

Genetics Has Revolutionized Parkinson’s Research. So What?

Genetics Has Revolutionized Parkinson’s Research. So What?

Mark R Cookson, PhD

Basic ScienceMark R Cookson, PhDJanuary 26, 2023Genetics, Therapies, Inflammation, Microglia, LRRK2, Eight Comment

Parkinson's disease, Precision Medicine, and LRRK2

by Matthew Farrer, PhD

Basic ScienceMatthew Farrer, PhDJanuary 22, 2018LRRK2, genetics, personalised medicine, twoComment

Planning For Prevention. It Is Time.

Planning For Prevention. It Is Time.

by Michael Schwarzschild, MD PhD

Clinical ScienceMichael Schwarzschild MD, PhDJanuary 3, 2018Prevention, neuroprotection, clinical trials, genetics, Prodromal, LRRK2, twoComment

The Role of Genetics in Personalized Medicine for Parkinson's Disease

The Role of Genetics in Personalized Medicine for Parkinson's Disease

by Nir Giladi, MD

Basic ScienceNir Giladi MDOctober 11, 2017Personalized Medicine, LRRK2, Genetics, FirstComment

Optimism from a Realist

Optimism from a Realist

by Kalpana Merchant, PhD

Basic ScienceKalpana Merchant PhDAugust 7, 2017PPMI, LRRK2, Genetics, August 2017, FirstComment

LRRK2: It’s Not All About The Neurons

LRRK2: It’s Not All About The Neurons

by Darcie A. Cook and Malú G. Tansey, PhD

Basic ScienceDarcie A. Cook PhD CandidateJuly 24, 2017LRRK2, Genetics, Inflammation, Immune System, iPD, FirstComment

To Predict and Prevent

To Predict and Prevent

by Matthew Farrer, PhD

Basic ScienceMatthew Farrer, PhDJuly 17, 2017Micheal J Fox, PPMI, Genetics, LRRK2, GBA, July 2017, FirstComment

Developing disease-modifying therapies in Parkinson’s Disease: The buzz about LRRK2 kinase inhibitors

Developing disease-modifying therapies in Parkinson’s Disease: The buzz about LRRK2 kinase inhibitors

by Andrew B. West, PhD

Photo Credit: Grove Ayers

Basic ScienceAndrew B. West, PhDJuly 10, 2017LRRK2, Michael J Fox, PPMI, Genetics, July 2017, one, FirstComment